Elutia Inc. Class A Common Stock
$0.82
$0.02 (+2.50%)
$0.79Day Range$0.83
Key Statistics
Market Cap
$35.43M
Shares Outstanding
44.3M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Oct 8, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$0.83
Day High
$0.83
Day Low
$0.79
Volume
8.0K
VWAP
$0.82
Prev Close
$0.80
Transactions
--
Acc. Volume
--
About Elutia Inc. Class A Common Stock
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)SIC 283626 employees12510 PROSPERITY DRIVE, SILVER SPRING, MD, 20904240-247-1143IPO Oct 8, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001708527
- Composite FIGI
- BBG00BRBB838
- Share Class FIGI
- BBG00BRBB847
- Ticker Root
- ELUT
- SIC Code
- 2836
About Elutia Inc. Class A Common Stock (ELUT) Stock
Elutia Inc. Class A Common Stock (ELUT) closed the 2026-09-16 session at $0.82, up 2.50% versus the previous close (+0.02). The stock opened at $0.83 and traded between $0.79 and $0.83 during that session. Session trading volume was 8K shares. The volume-weighted average price (VWAP) is $0.82.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Elutia Inc. Class A Common Stock has a market capitalization of $35.4 million. The company operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) industry classification. ELUT is listed on the XNAS exchange. The company employs approximately 26 people. Elutia Inc. Class A Common Stock is headquartered in SILVER SPRING, MD. The recorded listing date is 2020-10-08.
On this page you can find market ELUT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector.